| scholarly article | Q13442814 |
| P50 | author | Juan C Zapata | Q63378737 |
| P2093 | author name string | Maria S Salvato | |
| Jiabin Yan | |||
| Charles David Pauza | |||
| P2860 | cites work | IL-28B/IFN-lambda 3 drives granzyme B loading and significantly increases CTL killing activity in macaques | Q24630281 |
| Comparative ability of IL-12 and IL-28B to regulate Treg populations and enhance adaptive cellular immunity | Q24642027 | ||
| Cancer therapy using a self-replicating RNA vaccine | Q27481056 | ||
| FADD: a regulator of life and death | Q28286149 | ||
| Restoring function in exhausted CD8 T cells during chronic viral infection | Q28289222 | ||
| Survival function of the FADD-CASPASE-8-cFLIP(L) complex | Q28589465 | ||
| Safety and immunogenicity of an HIV-1 gag DNA vaccine with or without IL-12 and/or IL-15 plasmid cytokine adjuvant in healthy, HIV-1 uninfected adults | Q28740321 | ||
| GM-CSF increases mucosal and systemic immunogenicity of an H1N1 influenza DNA vaccine administered into the epidermis of non-human primates | Q28751705 | ||
| Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand | Q29547531 | ||
| HIV prevention transformed: the new prevention research agenda | Q30404963 | ||
| Increased DNA vaccine delivery and immunogenicity by electroporation in vivo | Q33899313 | ||
| Innate and adaptive immune correlates of vaccine and adjuvant-induced control of mucosal transmission of SIV in macaques | Q34006329 | ||
| Interplay between regulatory T cells and PD-1 in modulating T cell exhaustion and viral control during chronic LCMV infection | Q34089124 | ||
| Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity | Q47644096 | ||
| The need for IgG2c specific antiserum when isotyping antibodies from C57BL/6 and NOD mice. | Q47809273 | ||
| The degree of apoptosis as an immunostimulant for a DNA vaccine against HIV-1 infection. | Q54573275 | ||
| TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines | Q56897738 | ||
| Trypanosoma cruzi infection selectively renders parasite-specific IgG+ B lymphocytes susceptible to Fas/Fas ligand-mediated fratricide | Q58846261 | ||
| Targeted antigen delivery to antigen-presenting cells including dendritic cells by engineered Fas-mediated apoptosis | Q74268258 | ||
| Chemotactic activity of soluble Fas ligand against phagocytes | Q77483805 | ||
| Combined deficiency of proapoptotic regulators Bim and Fas results in the early onset of systemic autoimmunity | Q80703822 | ||
| Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection | Q34093225 | ||
| The many roles of FAS receptor signaling in the immune system | Q34205697 | ||
| Mitochondrial apoptosis is dispensable for NLRP3 inflammasome activation but non-apoptotic caspase-8 is required for inflammasome priming | Q34343275 | ||
| Mechanisms of HIV-associated lymphocyte apoptosis: 2010 | Q34545417 | ||
| Role of the Fas/FasL pathway in HIV or SIV disease | Q34612821 | ||
| Apoptosis is essential for the increased efficacy of alphaviral replicase-based DNA vaccines. | Q34703631 | ||
| CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells | Q34709777 | ||
| DNA vaccines: ready for prime time? | Q34824179 | ||
| Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine | Q35009558 | ||
| Enhancing DNA vaccine potency by coadministration of DNA encoding antiapoptotic proteins | Q35108258 | ||
| DNA vaccines and apoptosis: to kill or not to kill? | Q35108541 | ||
| Clinical applications of DNA vaccines: current progress | Q35452312 | ||
| Protective HIV-specific CD8+ T cells evade Treg cell suppression | Q35885111 | ||
| The Thai phase III trial (RV144) vaccine regimen induces T cell responses that preferentially target epitopes within the V2 region of HIV-1 envelope | Q36060423 | ||
| Vaccine Adjuvants: Putting Innate Immunity to Work | Q36168232 | ||
| Regulatory T cells, tumour immunity and immunotherapy | Q36430144 | ||
| Plasmid DNA vaccine-elicited cellular immune responses limit in vivo vaccine antigen expression through Fas-mediated apoptosis. | Q36488868 | ||
| Apoptosis regulators Fas and Bim cooperate in shutdown of chronic immune responses and prevention of autoimmunity | Q36501636 | ||
| Molecular basis of viral persistence: a single amino acid change in the glycoprotein of lymphocytic choriomeningitis virus is associated with suppression of the antiviral cytotoxic T-lymphocyte response and establishment of persistence. | Q36683932 | ||
| An attenuated Lassa vaccine in SIV-infected rhesus macaques does not persist or cause arenavirus disease but does elicit Lassa virus-specific immunity. | Q36698306 | ||
| Persistent LCMV infection is controlled by blockade of type I interferon signaling | Q36808119 | ||
| RNA interference-mediated in vivo silencing of fas ligand as a strategy for the enhancement of DNA vaccine potency | Q36983827 | ||
| CD4+ T lymphocytes mediate in vivo clearance of plasmid DNA vaccine antigen expression and potentiate CD8+ T-cell immune responses | Q37001971 | ||
| DNA vaccines: precision tools for activating effective immunity against cancer. | Q37064852 | ||
| Administration of HPV DNA vaccine via electroporation elicits the strongest CD8+ T cell immune responses compared to intramuscular injection and intradermal gene gun delivery | Q37351412 | ||
| DNA vaccines: an historical perspective and view to the future | Q37825523 | ||
| Electroporation delivery of DNA vaccines: prospects for success | Q37870313 | ||
| Targeting the Fas/FasL signaling pathway in cancer therapy. | Q37975245 | ||
| The adaptor protein FADD and the initiator caspase-8 mediate activation of NF-κB by TRAIL. | Q39253903 | ||
| Peptide antigen or superantigen-induced down-regulation of TCRs involves both stimulated and unstimulated receptors | Q41094201 | ||
| Blockade of chronic type I interferon signaling to control persistent LCMV infection | Q41807293 | ||
| Enzymatically active single chain caspase-8 maintains T-cell survival during clonal expansion | Q41828166 | ||
| NFkappaB activation by Fas is mediated through FADD, caspase-8, and RIP and is inhibited by FLIP. | Q41891932 | ||
| Comparative analysis of immune responses induced by vaccination with SIV antigens by recombinant Ad5 vector or plasmid DNA in rhesus macaques. | Q42076273 | ||
| Apoptosis-mediated enhancement of DNA-raised immune responses by mutant caspases | Q42828506 | ||
| Regulatory CD4+CD25+ T cells restrict memory CD8+ T cell responses | Q42947652 | ||
| Apoptosis regulators Bim and Fas function concurrently to control autoimmunity and CD8+ T cell contraction | Q43493690 | ||
| Increased regulatory T cell counts in HIV-infected nonresponders to hepatitis B virus vaccine. | Q45375182 | ||
| Moving ahead an HIV vaccine: to neutralize or not, a key HIV vaccine question | Q47575476 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P304 | page(s) | 1429-1453 | |
| P577 | publication date | 2015-03-23 | |
| P1433 | published in | Viruses | Q7935305 |
| P1476 | title | Modulation of SIV and HIV DNA vaccine immunity by Fas-FasL signaling | |
| P478 | volume | 7 |
| Q47233214 | E3L and F1L Gene Functions Modulate the Protective Capacity of Modified Vaccinia Virus Ankara Immunization in Murine Model of Human Smallpox | cites work | P2860 |
Search more.